{
  "id": "left-ventricular-hypertrophy",
  "title": "Left Ventricular Hypertrophy",
  "lang": "en",
  "source_lang": "en",
  "summary": "Left ventricular hypertrophy is an increase in the muscle mass of the heart’s main pumping chamber, often associated with high blood pressure or other cardiac conditions.",
  "category": "health",
  "subcategory": "diseases",
  "type": "concept",
  "aliases": [
    "LVH",
    "Left ventricular muscle hypertrophy"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/left-ventricular-hypertrophy/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/left-ventricular-hypertrophy/",
      "json": "https://aiwiki.page/zh/left-ventricular-hypertrophy.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Left ventricular hypertrophy (LVH) is an increase in the muscle mass of the left ventricle, the chamber of the heart that pumps blood into the systemic circulation. It commonly develops in response to sustained high blood pressure, but may also result from heart valve disease, inherited disorders of heart muscle, or physiological adaptation to intensive exercise. LVH is a structural finding rather than a single disease. Its significance depends on its cause, severity, associated changes in heart function, and whether it represents physiological adaptation or pathological remodeling."
    },
    {
      "heading": "Structure and mechanisms",
      "text": "The left ventricle generates the pressure needed to circulate blood through most of the body. When its workload increases over time, individual heart muscle cells can enlarge, increasing ventricular muscle mass. This process differs from simple ventricular dilation, in which the chamber becomes larger, although hypertrophy and dilation can occur together.\n\nTwo broad patterns of increased workload contribute to LVH:\n\n- Pressure overload: The ventricle pumps against increased resistance, as in hypertension or aortic stenosis, a narrowing of the aortic valve. The ventricular walls often become thicker relative to the chamber size.\n- Volume overload: The ventricle handles an increased volume of blood, as may occur when certain heart valves leak. The chamber often enlarges along with an increase in muscle mass.\n\nInitially, increased muscle mass can help maintain pumping performance. In pathological LVH, however, prolonged stress may also produce fibrosis, altered small-vessel function, increased oxygen demand, and impaired relaxation. The ventricle may consequently require higher filling pressures even while its ability to eject blood remains preserved.\n\nHormonal signaling, including activation of the renin–angiotensin–aldosterone system, contributes to muscle growth and tissue remodeling."
    },
    {
      "heading": "Causes and associated conditions",
      "text": "Hypertension and valve disease\n\nSustained hypertension is a major cause of LVH. The likelihood and extent of hypertrophy depend on the duration and severity of elevated blood pressure as well as age, body size, and other factors. Aortic stenosis also imposes pressure overload on the left ventricle. Aortic or mitral valve regurgitation can increase ventricular volume load and muscle mass.\n\nObesity and chronic kidney disease are associated with LVH through overlapping effects on blood pressure, circulating volume, and metabolic or hormonal regulation.\n\nHeart muscle disorders and infiltrative disease\n\nHypertrophic cardiomyopathy is a distinct heart muscle disorder characterized by increased ventricular wall thickness that is not explained solely by abnormal loading conditions. It is frequently associated with inherited changes affecting cardiac muscle proteins. LVH caused by hypertension is therefore not synonymous with hypertrophic cardiomyopathy.\n\nSome disorders produce increased wall thickness through mechanisms other than enlargement of muscle cells alone. For example, amyloidosis can cause abnormal protein deposition within cardiac tissue. Such conditions may resemble ordinary hypertrophy on initial imaging but have different underlying pathology.\n\nPhysiological adaptation\n\nIntensive athletic training can increase ventricular mass as part of the “athlete’s heart.” Physiological remodeling generally occurs alongside adaptations in chamber size and function. Distinguishing it from disease may require assessment of training history, symptoms, family history, electrical findings, and imaging characteristics; no single wall-thickness measurement reliably resolves every case."
    },
    {
      "heading": "Geometric patterns",
      "text": "Ventricular geometry is commonly described using both left ventricular mass and relative wall thickness, a measure of wall thickness in relation to chamber size:\n\nPattern | Left ventricular mass | Relative wall thickness\nNormal geometry | Normal | Normal\nConcentric remodeling | Normal | Increased\nConcentric hypertrophy | Increased | Increased\nEccentric hypertrophy | Increased | Normal or relatively low\n\nConcentric remodeling is not itself LVH because ventricular mass is not increased. “Eccentric” hypertrophy refers to the relationship between muscle mass and chamber size, not necessarily to uneven thickening. Asymmetric wall thickening is a separate description.\n\nThese categories characterize structure but do not independently establish the cause."
    },
    {
      "heading": "Clinical features",
      "text": "LVH frequently causes no symptoms and may be discovered during investigation of hypertension or another cardiovascular condition. When symptoms occur, they may reflect the underlying disease or associated impairment of heart function. Possible manifestations include shortness of breath, reduced exercise tolerance, chest pain, and palpitations.\n\nClinical examination may identify elevated blood pressure, a sustained or displaced apical impulse, or a murmur suggesting valve disease. These findings alone do not reliably confirm or exclude LVH."
    },
    {
      "heading": "Diagnosis and measurement",
      "text": "Electrocardiography\n\nElectrocardiography can show increased electrical voltages and changes in ventricular repolarization associated with LVH. Several voltage-based criteria are used, including the Sokolow–Lyon and Cornell criteria.\n\nElectrical criteria do not directly measure muscle mass. Their diagnostic sensitivity and specificity vary with the criterion and the population examined. Body build, obesity, age, and athletic training affect interpretation. A normal electrocardiogram does not exclude anatomical LVH, while high voltage does not always indicate increased ventricular mass.\n\nEchocardiography\n\nEchocardiography, a cardiac application of ultrasonography, measures ventricular dimensions and wall thickness and can estimate left ventricular mass. It also evaluates valve disease, pumping function, relaxation, and filling pressures.\n\nMass is commonly indexed to body surface area or a height-based measure to account for body size. With a widely used adult echocardiographic method, upper reference limits for mass indexed to body surface area are approximately \\(115\\ \\text{g/m}^2\\) in men and \\(95\\ \\text{g/m}^2\\) in women. These are method-specific reference values rather than universal diagnostic boundaries. Interpretation differs in children, athletes, and people with marked obesity, and varies with the imaging technique and indexing approach.\n\nCardiac magnetic resonance\n\nCardiac magnetic resonance imaging provides detailed measurements of ventricular mass, volumes, and the distribution of wall thickening. Tissue characterization can help distinguish pressure-related remodeling from cardiomyopathy, infiltration, and fibrosis, particularly when echocardiographic findings are inconclusive."
    },
    {
      "heading": "Clinical significance and management",
      "text": "Pathological LVH is associated with increased risks of heart failure, atrial fibrillation, ventricular arrhythmias, and other cardiovascular events. Impaired relaxation can contribute to heart failure even when the proportion of blood ejected with each beat remains normal. Risk varies substantially according to the underlying cause, degree of hypertrophy, fibrosis, and coexisting disease.\n\nManagement is directed at the cause rather than ventricular thickness alone. In hypertension-associated LVH, sustained blood-pressure reduction can reduce ventricular mass. Correction of significant valve disease may also permit regression of hypertrophy. Cardiomyopathies and infiltrative disorders require disease-specific assessment and treatment.\n\nRegression of LVH is associated with better cardiovascular outcomes, but it does not necessarily mean that all tissue abnormalities have resolved. Follow-up assessment considers the underlying disease, blood pressure, symptoms, ventricular function, and changes in cardiac structure."
    }
  ],
  "links": [
    "hypertension",
    "fibrosis",
    "renin-angiotensin-aldosterone-system",
    "obesity",
    "chronic-kidney-disease",
    "shortness-of-breath",
    "chest-pain",
    "palpitations",
    "diagnostic-sensitivity-and-specificity",
    "ultrasonography",
    "magnetic-resonance-imaging",
    "atrial-fibrillation"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}